Oncotarget

Withdrawal Notice

This paper was originally published in Oncotarget Advance Online Publications on 12/26/2017.
In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.

Clinical Research Papers:

EGFR exon 19 deletion is associated with favorable overall survival after first-line icotinib therapy in advanced non-small cell lung cancer patients: a retrospective, multiple-center, real-world study

Chuantao Zhang, Helei Hou, Xin Cheng, Dianxia Gong, Ling Yang, Haixin Liu, Wenyong Zhu, Na Zhou, Yan Zhu, Ling Chen, Kewei Liu, Jingjuan Zhu, Hongying Lv, Tianjun Li, Dong Liu, Jing Cong, Man Jiang, Yakun Zhang, Hualong Yu, Hongsheng Yu and Xiaochun Zhang _

 

Chuantao Zhang1,2,*, Helei Hou1,2,*, Xin Cheng3, Dianxia Gong4, Ling Yang5, Haixin Liu5, Wenyong Zhu6, Na Zhou1,2, Yan Zhu5, Ling Chen5, Kewei Liu1,2, Jingjuan Zhu1,2, Hongying Lv1,2, Tianjun Li1,2, Dong Liu1,2, Jing Cong1,2, Man Jiang1,2, Yakun Zhang5, Hualong Yu1,2, Hongsheng Yu1,2 and Xiaochun Zhang1,2

1Qingdao University, Qingdao, Shandong, China

2Department of Medical Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

3Department of Medical Oncology, Qingdao Center Medical Group, No. 2 Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

4Department of Medical Oncology, Ju Xian People’s Hospital, Rizhao, Shandong, China

5Department of Medical Oncology, Qingdao Municipal Hospital, No. 3 Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

6Department of Thoracic Surgery, Qilu Hospital of Shandong University, Qingdao, Shandong, China

*These authors contributed equally to this work

Correspondence to:

Xiaochun Zhang, email: [email protected]

Keywords: non-small cell lung cancer; epidermal growth factor receptor mutation; icotinib

Received: September 04, 2017     Accepted: December 15, 2017     Published: December 26, 2017


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 23720